SC 13D/A

AMENDMENT NO. 2 TO THE SCHEDULE 13D

Company: Aurinia Pharmaceuticals Inc.
Filed: January 18, 2019
Accession Number: 0000921895-19-000115

View Document ↗ View on SEC.gov ↗